Document is current

Article History

Received: 10 February 2022

Accepted: 9 August 2022

First Online: 20 August 2022

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the IRB. The study was approved by the IRBs of Dana-Farber Harvard Cancer Center, and other participating sites (Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, Cape Cod Hospital, Lowell General Hospital, Massachusetts General Hospital, Mayo Clinic, Newton-Wellesley Hospital, North Shore Cancer Center Salem, South Shore Hospital, Sunnybrook Health Sciences Centre, and University of Colorado Hospital).

: Informed consent was obtained from all individuals included in the study.

: S.M.R. reports grants from the Agency for Healthcare Research and Quality, during the conduct of the study and current grant funding from Pfizer. R.M.T. reports grants from the NIH/NCI, during the conduct of the study. J.P. reports personal fees from GlaxosmithKline (Spouse, employment), grants from Outcomes4Me Inc, personal fees from Athenex, and personal fees from Abbott Labs, outside the submitted work. A.H.P. receives royalties for co-authoring the Breast Cancer Survivorship section of UpToDate. All other authors declare no competing interests.

: The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.